Your browser doesn't support javascript.
loading
Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.
Venetsanos, D; Omerovic, E; Sarno, G; Pagonis, C; Witt, N; Calais, F; Böhm, F; Jurga, J; Völz, S; Koul, S; Olivercrona, G; James, S; Alfredsson, J.
Afiliación
  • Venetsanos D; Division of Cardiology, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden. Electronic address: dimitrios.venetsanos@liu.se.
  • Omerovic E; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden.
  • Sarno G; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Pagonis C; Department of Cardiology and Department of Health, Medical and caring Sciences, Linköping University, Linköping, Sweden.
  • Witt N; Department of Clinical Science and Education, Division of Cardiology, Södersjukhuset AB, Karolinska Institute, Stockholm, Sweden.
  • Calais F; Örebro University, Faculty of Health, Department of Cardiology, Örebro, Sweden.
  • Böhm F; Division of Cardiology, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • Jurga J; Division of Cardiology, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • Völz S; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden.
  • Koul S; Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.
  • Olivercrona G; Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.
  • James S; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Alfredsson J; Department of Cardiology and Department of Health, Medical and caring Sciences, Linköping University, Linköping, Sweden.
Int J Cardiol ; 325: 30-36, 2021 02 15.
Article en En | MEDLINE | ID: mdl-32980433
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Preparaciones Farmacéuticas / Fármacos Cardiovasculares / Reestenosis Coronaria / Stents Liberadores de Fármacos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cardiol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Preparaciones Farmacéuticas / Fármacos Cardiovasculares / Reestenosis Coronaria / Stents Liberadores de Fármacos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cardiol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos